MedPage Today on MSN
Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program
The drug discount program is under scrutiny on a variety of fronts ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...
The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.
A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state. | A Minnesota analysis of providers' reported ...
The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...
The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...
Drug companies are more likely than hospitals to violate 340B regulations, according to a recent American Hospital Association report. The 340B Drug Pricing Program has been under constant attack on ...
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
Facing ongoing concerns about rural hospital closures, Capitol Hill lawmakers have introduced a spate of proposals to fix a federal program created to keep lifesaving services in small towns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results